← Signals · Healthcare · TSX
$EPRX
Eupraxia Pharmaceuticals
Signal as of September 24, 2026  ·  90-day rolling window  ·  Biotechnology & Life Sciences
Confluence Score
60
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 40–59 have historically hit 41% of the time (avg +7.1% over 90 days, 4424 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
📅 Buying into earnings — Nov 03 (33d)
Confluence Score
60
Insider Activity (90d)
1
1 buyer  ·  $150K  ·  open-market only
Current Price
$12.99
CAD  ·  5-min cache
Market Cap
$845M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Healthcare on Form55: 56% hit rate · -2.8% alpha vs XIU.TO · 27 closed signals Track Record →
★
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSX:EPRX
Insider Transactions
90-day window  ·  1 filing
Date Insider Role Nature Dir. Shares Buy Price Return Value
Aug 19, 2026 Montalbano, John — Open Market Buy 22,000 $6.82 +90.5%  · 43d $150K
Score uses open-market buys only  ·  1 open-market  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 30 30 1 unique buyer (maximum conviction)
Buy/sell ratio 20 100% buys (1B / 0S)
Dollar value 25 $150K
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 Avg 21% credibility (limited data)
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 1 insider reversed from selling to buying
Total 60 100
Unlock Component Detail — CAD $29/mo
Buying Insiders
Open-market · 90 days · 1 unique buyer
Insider Credibility Hit Rate Avg 90d Return Trades (eval'd) Buy Value (90d) Last Buy
Montalbano, John 21 /100 50% +19.1% 10 $150K Aug 19, 2026
Credibility score: historical hit rate × avg 90d return × sample size. View full insider leaderboard →
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Political Footprint
Donations · lobbying · contracts

4 insiders linked to EPRX are also individual political donors — $6K across 7 donations (2013–2023).

Conservative Party of Canada · $6K

Sources: Elections Canada (individual donations only — corporate political donations banned federally since 2007), the federal Registry of Lobbyists, and federal contract disclosures. Insiders matched to donors by name. Shown for transparency from disclosed public records — this is not a Confluence Score input, implies no causal link between donations, lobbying, or contracts, and is not a claim of wrongdoing.

Indigenous Consultation
no records on file

No Indigenous consultation records on file for EPRX.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Sep 15, 2026
Shares short
98,783
Net change
-2,241 (-2.2%)
History
Sep 15: 98,783
Aug 31: 101,024
Aug 15: 43,637
Jul 31: 88,444
Jul 15: 52,131
Jun 30: 67,030
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Clinical Trials
ClinicalTrials.gov  ·  3 trials
Phase Status Trial Updated
P1/P2 Recruiting A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis ( Mar 2026
P2 Completed Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients Wit Jun 2024
P1 Completed Safety Study of a Long-Acting Injectable Steroid to Treat Knee Osteoar Sep 2021
Trials where this company is the lead sponsor (ClinicalTrials.gov). Phase advances, completions and terminations are material catalysts for clinical-stage companies — not investment advice.
Boardroom Connections
1 insider also active elsewhere
Insider Other boards Also an insider at
Montalbano, John 1 MFC (34)
People who file as insiders here and at other TSX/TSXV companies (number in brackets = that company's Confluence Score). A well-connected insider taking a seat at a new junior can be an early tell. Matched by name across SEDI filings; funds and 10%+ holders excluded.
Government Grants & Funding
21 federal awards  ·  $4.8M total
Program / Agreement Department Amount Start
Industrial Research Assistance Program – Contributions to Firms Contribution National Research Council Canada $700K Sep 2021
Industrial Research Assistance Program – Youth Employment Progra Contribution National Research Council Canada $36K Apr 2021
Industrial Research Assistance Program – Innovation Assistance P Contribution National Research Council Canada $76K Dec 2020
Industrial Research Assistance Program – Innovation Assistance P Contribution National Research Council Canada $202K Jun 2020
Innovation Assistance Program Contribution National Research Council Canada $142K Apr 2020
Industrial Research Assistance Program – Contributions to Firms Contribution National Research Council Canada $999K Feb 2019
Industrial Research Assistance Program – Contributions to Firms Contribution National Research Council Canada $924K Feb 2019
Research Training and Talent Development Grant Natural Sciences and Engineering Research Council of Canada $4K Jan 2019
Research Training and Talent Development Grant Natural Sciences and Engineering Research Council of Canada $5 Jan 2019
Research Training and Talent Development Grant Natural Sciences and Engineering Research Council of Canada $4K Sep 2018
Research Training and Talent Development Grant Natural Sciences and Engineering Research Council of Canada $4K May 2018
Research Training and Talent Development Grant Natural Sciences and Engineering Research Council of Canada $4K May 2018
Federal grants & contributions disclosed by the Government of Canada (Proactive Disclosure), matched to this issuer by legal name. Government funding can be a pre-revenue validation and capital signal. Display-only context, not a Confluence Score input.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.